Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in cancer pain therapy.

J S Chiang1

  • 1Department of Anesthesiology, University of Texas, M.D. Anderson Cancer Center, Houston, USA.

Acta Anaesthesiologica Sinica
|September 23, 2000
PubMed
Summary

This review covers new drugs and therapies for cancer pain management, including breakthrough pain relief and novel delivery systems. It highlights sustained-release opioids, COX-2 inhibitors, and other agents for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Undergraduate medical education in pain medicine, end-of-life care, and palliative care.

Pain medicine (Malden, Mass.)·2004
Same author

Postoperative pain management.

International anesthesiology clinics·2000
Same author

Intraspinal opioid therapy for intractable cancer pain.

International anesthesiology clinics·2000
See all related articles

Area of Science:

  • Oncology
  • Pain Management
  • Pharmacology

Background:

  • Cancer pain is a significant challenge impacting patient quality of life.
  • Existing treatments for cancer pain have limitations and side effects.
  • Novel pharmacological and delivery system approaches are needed for effective cancer pain management.

Purpose of the Study:

  • To review emerging drugs and therapies for cancer pain.
  • To discuss agents for breakthrough cancer pain.
  • To explore new sustained-release opioids and other analgesic classes.

Main Methods:

  • Literature review of recent advancements in cancer pain management.
  • Summary of clinical applications and future potential of new therapies.
  • Categorization of drugs including opioids, NSAIDs, alpha-2 agonists, and receptor antagonists.

Main Results:

  • Identification of several promising drug classes for cancer pain.
  • Discussion of novel delivery systems for improved efficacy.
  • Overview of agents targeting specific pain mechanisms like COX-2 and NMDA receptors.

Conclusions:

  • New pharmacological agents and delivery systems offer improved cancer pain control.
  • The reviewed therapies hold promise for managing breakthrough pain and chronic cancer pain.
  • Future research should focus on optimizing these novel treatments for diverse patient populations.

Related Experiment Videos